Akèy › Tit travay › Research Associate II
Research Associate II: Salè H-1B
388 aplikasyon kondisyon travay te itilize tit travay Research Associate II. Salè baz medyàn ofri $72,000; mwatye mitan $63,694–$82,416.
Demann (LCA)388
Salè medyan ofri$72,000
Mwatye salè yo$63,694–$82,416
10yèm–90yèm pousantaj$57,202–$89,557
Avoka imigrasyon, rekritè oswa anplwayè? Mete sèvis ou an tèt paj sa a — $99 pou 30 jou →
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|
| Rutgers, The State University of New Jersey | 47 | $67,074 |
| Colorado State University | 16 | $64,374 |
| Tessera Therapeutics, Inc. | 15 | $82,500 |
| The Broad Institute, Inc. | 11 | $59,000 |
| Entrada Therapeutics, Inc. | 10 | $83,000 |
| HD Biosciences, Inc. | 9 | $55,000 |
| The Methodist Hospital Research Institute | 9 | $73,320 |
| CZ Biohub SF, LLC | 7 | $76,461 |
| Georgia State University | 7 | $72,080 |
| The Henry M. Jackson Foundation | 7 | $68,500 |
| Medical College of Wisconsin, Inc. | 6 | $61,153 |
| The J. David Gladstone Institutes | 6 | $66,560 |
| The University of Tennessee | 6 | $63,250 |
| CRISPR Therapeutics, Inc. | 6 | $91,198 |
| H. Lee Moffitt Cancer Center & Research Institute, Inc. | 5 | $39,604 |
| Allen Institute | 5 | $64,200 |
| University of Massachusetts Chan Medical School | 5 | $44,000 |
| Tufts Medical Center, Inc. | 5 | $78,786 |
| World Resources Institute | 4 | $106,914 |
| University of South Alabama | 4 | $67,008 |
| Generate Biomedicines, Inc. | 4 | $79,000 |
| Evidera, Inc. | 4 | $81,250 |
| Takeda Development Center Americas, Inc. | 4 | $82,575 |
| KBI Biopharma, Inc. | 4 | $63,710 |
| South Dakota State University | 3 | $56,712 |
| Ring Therapeutics, Inc. | 3 | $80,000 |
| Metaphore Biotechnologies, Inc. | 3 | $82,000 |
| Metagenomi, Inc. | 3 | $90,000 |
| Lonza Houston Inc | 3 | $69,993 |
| Auburn University | 3 | $65,324 |
| Institute for Protein Innovation Inc. | 3 | $75,130 |
| Aegea Biotechnologies, Inc. | 3 | $65,354 |
| Adjuvia Therapeutics, Inc. | 3 | $68,661 |
| UMass Chan Medical School | 2 | $65,853 |
| Imvela Corp | 2 | $85,000 |
| Novartis Institutes for BioMedical Research, Inc. | 2 | $79,020 |
| ImmunityBio, Inc. | 2 | $85,497 |
| Bio-Rad Laboratories, Inc. | 2 | $72,675 |
| Takara Bio USA Inc. | 2 | $98,620 |
| Flagship Labs 89, Inc. | 2 | $80,000 |
| National Institute of Statistical Sciences | 2 | $66,248 |
| Voyager Therapeutics, Inc. | 2 | $86,621 |
| Kallyope Inc. | 2 | $85,000 |
| Florida Institute of Technology | 2 | $95,918 |
| University of Illinois at Chicago | 2 | $60,248 |
| Apriori Bio, Inc. | 2 | $91,500 |
| Case Western Reserve University | 2 | $62,000 |
| Mississippi State University | 2 | $57,000 |
| Affini-T Therapeutics, Inc. | 2 | $82,466 |
| Arc Research Institute | 2 | $73,700 |
| Flagship Labs 85, Inc. | 2 | $85,000 |
| Sail Biomedicines, Inc. | 2 | $75,000 |
| University of Idaho | 2 | $56,649 |
| Vesalius Therapeutics, Inc. | 2 | $83,500 |
| Cystic Fibrosis Foundation | 2 | $79,500 |
| Altos Labs Inc. | 2 | $90,900 |
| Populus Group LLC | 2 | $104,000 |
| Ampersand Biomedicines, Inc. | 2 | $77,500 |
| The University of Alabama in Huntsville | 2 | $60,000 |
| ION Biosciences, LLC | 2 | $63,170 |
Pa nivo salè
| Nivo revni | Salè medyan |
|---|
| Nivo I (antre) | $75,000 |
| Nivo II (kalifye) | $72,300 |
| Nivo III (eksperyans) | $68,000 |
| Nivo IV (plen kompetans) | $83,682 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|
| FY2023 | 92 | $66,830 |
| FY2024 | 110 | $73,510 |
| FY2025 | 94 | $74,447 |
| FY2026 | 80 | $70,762 |
Vil yo
- Cambridge, MA48
- Boston, MA30
- Newark, NJ27
- Somerville, MA21
- San Francisco, CA17
- San Diego, CA15
- Fort Collins, CO14
- Houston, TX13
- New Brunswick, NJ12
- Piscataway, NJ9
- Worcester, MA8
- Seattle, WA7
- Milwaukee, WI6
- Washington, DC6
- South San Francisco, CA6
- Lexington, MA6
- Knoxville, TN6
- Atlanta, GA6
- Tampa, FL5
- New York, NY5
- Durham, NC5
- Bethesda, MD4
- Waltham, MA4
- Mobile, AL4
- Watertown, MA4
- Brookings, SD3
- La Jolla, CA3
- Emeryville, CA3
- Chicago, IL3
- Auburn, AL3
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).